News | Clinical Decision Support | February 11, 2019

New Appropriate Use Criteria Outlined for Multimodality Imaging of Nonvalvular Heart Disease

Guidance document from 10 societies discusses assessment of cardiac structure and function

New Appropriate Use Criteria Outlined for Multimodality Imaging of Nonvalvular Heart Disease

February 11, 2019 β€” The American College of Cardiology (ACC), along with nine other cardiology professional societies, recently published a new guidance document for appropriate use criteria (AUC) for multimodality imaging in the assessment of cardiac structure and function in nonvalvular heart disease. The guidance was published online Jan. 7 in the Journal of the American College of Cardiology (JACC).Β Β 

This document is the second of two companion AUC documents. The first document addresses the evaluation and use of multimodality imaging in the diagnosis and management of valvular heart disease, whereas this document addresses this topic with regard to structural (nonvalvular) heart disease. While dealing with different subjects, the two documents do share a common structure and feature some clinical overlap. The goal of the companion AUC documents is to provide a comprehensive resource for multimodality imaging in the context of structural and valvular heart disease, encompassing multiple imaging modalities.

For more information: www.acc.org

Β 

Reference

1. Doherty J.U., Kort S., Mehran R., et al. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease. Journal of the American College of Cardiology, Jan. 7, 2019. https://doi.org/10.1016/j.jacc.2018.10.038


Related Content

News | Cardiac Imaging

March 28, 2026 β€” When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it ...

Home April 01, 2026
Home
News | Cardiac Imaging

March 18, 2026 β€” Circle Cardiovascular Imaging (Circle CVI) has announced the expansion of its cvi42 cardiovascular ...

Home March 20, 2026
Home
News | Cardiac Imaging

March 19, 2026 β€” Heart disease is the leading cause of adult death worldwide, making cardiovascular disease diagnosis ...

Home March 20, 2026
Home
News | Cardiac Imaging

March 16, 2026 β€” The American Society for Preventive Cardiology (ASPC) will host its 2026 Virtual Imaging Symposium, a ...

Home March 17, 2026
Home
Feature | Cardiac Imaging

Sponsored Content β€” According to the American Heart Association, cardiovascular disease is the leading cause of death in ...

Home March 13, 2026
Home
News | Cardiac Imaging

March 6, 2026 β€” Building on its leadership in cardiac MR, Philips has received FDA 510(k) clearance for SmartHeart, an ...

Home March 09, 2026
Home
News | Cardiac Imaging

Feb. 26, 2026 β€” The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...

Home February 26, 2026
Home
News | Cardiac Imaging

Feb. 13, 2026 β€” Conavi Medical Corp. recently highlighted the publication of new peer-reviewed research titled β€œDeep ...

Home February 16, 2026
Home
News | Cardiac Imaging

Jan. 27. 2026 β€” Circle Cardiovascular Imaging Inc. has announced the release of cvi42 v6.4, the latest version of its ...

Home January 28, 2026
Home
News | Cardiac Imaging

Jan. 6, 2026 β€” UltraSight, a provider of AI-guided cardiac imaging workflows, has announced FDA clearance to expand its ...

Home January 16, 2026
Home
Subscribe Now